CliffBio
small molecule

OMEPRAZOLE MAGNESIUM

OMEPRAZOLE MAGNESIUM

Loss of exclusivity—loss of exclusivity
CompanyDEXCEL PHARMA TECHNOLOGIES LTD

Drug detail

Brand nameOMEPRAZOLE MAGNESIUM
Active ingredientOMEPRAZOLE MAGNESIUM
StrengthEQ 20MG BASE
Dosage formCAPSULE, DELAYED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalMay 2022
Marketing statusOTC

More from DEXCEL PHARMA TECHNOLOGIES LTD

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

OMEPRAZOLE MAGNESIUM patent cliff — loss of exclusivity — | CliffBio